drugset / Trial / NCT00276315
Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
RandomizedParallel-groupSingle-blindTreatment
Summary
To compare the effectiveness and safety of Dysport® with the domestic Botulinum Toxin Type A (manufactured by Lanzhou Biologic Product Institute, P.R. China) for the treatment of hemifacial spasm.
Timeline
- Start
- 2005-12
- Primary completion
- —
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |